Blood and plasma contain enzymes that can hydrolyze some labile groups such as esters or amides.
It is important to determine plasma stability of a new molecule because compounds rapidly degraded in plasma generally have low activity in vivo.
Conversely, in the case of "prodrugs", the hydrolysis of labile groups makes it possible to increase the pharmacological activity.
